Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Similar articles for PubMed (Select 16639734)

1.

Impact of age on outcome of pediatric acute myeloid leukemia: a report from 2 institutions.

Razzouk BI, Estey E, Pounds S, Lensing S, Pierce S, Brandt M, Rubnitz JE, Ribeiro RC, Rytting M, Pui CH, Kantarjian H, Jeha S.

Cancer. 2006 Jun 1;106(11):2495-502.

2.
3.

Relationships between age at diagnosis, clinical features, and outcome of therapy in children treated in the Medical Research Council AML 10 and 12 trials for acute myeloid leukemia.

Webb DK, Harrison G, Stevens RF, Gibson BG, Hann IM, Wheatley K; MRC Childhood Leukemia Working Party.

Blood. 2001 Sep 15;98(6):1714-20.

4.

Prognostic significance of myeloperoxidase expression in childhood acute myeloid leukemia.

Roberson JR, Onciu M, Pounds S, Rubnitz JE, Pui CH, Razzouk BI.

Pediatr Blood Cancer. 2008 Mar;50(3):542-8.

PMID:
17763467
5.

Comparison of childhood myelodysplastic syndrome, AML FAB M6 or M7, CCG 2891: report from the Children's Oncology Group.

Barnard DR, Alonzo TA, Gerbing RB, Lange B, Woods WG; Children's Oncology Group.

Pediatr Blood Cancer. 2007 Jul;49(1):17-22.

PMID:
16856158
6.

Clinical and biologic features and treatment outcome of children with newly diagnosed acute myeloid leukemia and hyperleukocytosis.

Inaba H, Fan Y, Pounds S, Geiger TL, Rubnitz JE, Ribeiro RC, Pui CH, Razzouk BI.

Cancer. 2008 Aug 1;113(3):522-9. doi: 10.1002/cncr.23581.

7.

Effect of race on outcome of white and black children with acute myeloid leukemia: the St. Jude experience.

Rubnitz JE, Lensing S, Razzouk BI, Pounds S, Pui CH, Ribeiro RC.

Pediatr Blood Cancer. 2007 Jan;48(1):10-5.

PMID:
16642489
8.

Prognostic factors and outcome of recurrence in childhood acute myeloid leukemia.

Rubnitz JE, Razzouk BI, Lensing S, Pounds S, Pui CH, Ribeiro RC.

Cancer. 2007 Jan 1;109(1):157-63.

9.

Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: comparison with adult acute myeloid leukemia.

Verstovsek S, Manshouri T, Smith FO, Giles FJ, Cortes J, Estey E, Kantarjian H, Keating M, Jeha S, Albitar M.

Cancer. 2003 May 1;97(9):2212-7.

10.

Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.

Tomizawa D, Tabuchi K, Kinoshita A, Hanada R, Kigasawa H, Tsukimoto I, Tsuchida M; Tokyo Children's Cancer Study Group.

Pediatr Blood Cancer. 2007 Aug;49(2):127-32.

PMID:
16807916
11.

Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961.

Barbaric D, Alonzo TA, Gerbing RB, Meshinchi S, Heerema NA, Barnard DR, Lange BJ, Woods WG, Arceci RJ, Smith FO.

Blood. 2007 Mar 15;109(6):2314-21. Epub 2006 Dec 7.

12.

Adverse prognostic features in 251 children treated for acute myeloid leukemia.

Hurwitz CA, Schell MJ, Pui CH, Crist WM, Behm F, Mirro J Jr.

Med Pediatr Oncol. 1993;21(1):1-7.

PMID:
8426571
13.

Risk factors and therapy for isolated central nervous system relapse of pediatric acute myeloid leukemia.

Johnston DL, Alonzo TA, Gerbing RB, Lange BJ, Woods WG.

J Clin Oncol. 2005 Dec 20;23(36):9172-8.

14.

Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience.

Rubnitz JE, Lensing S, Zhou Y, Sandlund JT, Razzouk BI, Ribeiro RC, Pui CH.

Cancer. 2004 Oct 1;101(7):1677-84.

15.

Splenic rupture in children with hematologic malignancies.

Athale UH, Kaste SC, Bodner SM, Ribeiro RC.

Cancer. 2000 Jan 15;88(2):480-90.

PMID:
10640983
16.

Improved outcome for children with acute lymphoblastic leukemia after risk-adjusted intensive therapy: a single-institution experience.

Al-Nasser A, El-Solh H, De Vol E, El-Hassan I, Alzahrani A, Al-Sudairy R, Al-Mahr M, Al-Musa A, Al-Jefri A, Saleh M, Rifai S, Belgaumi A, Osman L, Ashraf K, Salim M, Silo A, Roberts G.

Ann Saudi Med. 2008 Jul-Aug;28(4):251-9.

PMID:
18596394
17.

Long-term outcomes of myeloablation and autologous transplantation of relapsed acute myeloid leukemia in second remission: a British Society of Blood and Marrow Transplantation registry study.

Chantry AD, Snowden JA, Craddock C, Peggs K, Roddie C, Craig JI, Orchard K, Towlson KE, Pearce RM, Marks DI; BSBMT Clinical Trials Committee.

Biol Blood Marrow Transplant. 2006 Dec;12(12):1310-7.

18.

Matched unrelated or matched sibling donors result in comparable survival after allogeneic stem-cell transplantation in elderly patients with acute myeloid leukemia: a report from the cooperative German Transplant Study Group.

Schetelig J, Bornhäuser M, Schmid C, Hertenstein B, Schwerdtfeger R, Martin H, Stelljes M, Hegenbart U, Schäfer-Eckart K, Füssel M, Wiedemann B, Thiede C, Kienast J, Baurmann H, Ganser A, Kolb HJ, Ehninger G.

J Clin Oncol. 2008 Nov 10;26(32):5183-91. doi: 10.1200/JCO.2007.15.5184. Epub 2008 Sep 2.

19.

Primary myelosarcomas are associated with a high rate of relapse: report on 34 children from the acute myeloid leukaemia-Berlin-Frankfurt-Münster studies.

Reinhardt D, Pekrun A, Lakomek M, Zimmermann M, Ritter J, Creutzig U.

Br J Haematol. 2000 Sep;110(4):863-6.

PMID:
11054069
20.

Cytogenetics and age are major determinants of outcome in intensively treated acute myeloid leukemia patients older than 60 years: results from AMLSG trial AML HD98-B.

Fröhling S, Schlenk RF, Kayser S, Morhardt M, Benner A, Döhner K, Döhner H; German-Austrian AML Study Group.

Blood. 2006 Nov 15;108(10):3280-8. Epub 2006 Jul 13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk